IN8BIO shares outstanding INAB
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 19.5M
- On a year earlier
- +372.6%
- more shares
IN8BIO had 19.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 372.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 7.1M | +173% |
| FY2024 | 2.6M | +125% |
| FY2023 | 1.2M | +41% |
| FY2022 | 817K | +31% |
| FY2021 | 625.7K | +445% |
| FY2020 | 114.9K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 19.5M | +373% | |
| Q1 FY26 | 19.5M | +656% | |
| Q4 FY25 | 7.1M | +173% | |
| Q3 FY25 | 4.5M | +188% | |
| Q2 FY25 | 4.1M | +163% | |
| Q1 FY25 | 2.6M | +78% | |
| Q4 FY24 | 2.6M | +125% | |
| Q3 FY24 | 1.6M | +50% | |
| Q2 FY24 | 1.6M | +65% | |
| Q1 FY24 | 1.4M | +75% | |
| Q4 FY23 | 1.2M | +41% | |
| Q3 FY23 | 1.1M | +46% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on IN8BIO
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.